North America Nutrigenomics Market 2021-2031

North America nutrigenomics market is projected to grow by 14.8% annually in the forecast period and reach $986.4 million by 2031, driven by the advancements in nutritional & medical technology, the increasing rate of obesity and lifestyle-related diseases, increasing awareness about the relationship between nutrition/gene/health, personalized diet and genetic nutrition profile, and the increasing family disposable incomes. Highlighted with 25 tables and 55 figures, this 115-page report “North America Nutrigenomics Market 2021-2031 by Offering (Products, Testing Services), Test Technology, Test Sample (Buccal Swab, Saliva, Blood, Others), Application (Women’s Health, Metabolic Disorders, Immune Health, Cancer, Cardiovascular, Diabetes), End User, and Country: Trend Forecast and Growth Opportunity” is based on a comprehensive research of the entire North America nutrigenomics market and all its sub-segments through extensively detailed classifications. Profound analysis and assessment are generated from premium primary and secondary information sources with inputs derived from industry professionals across the value chain. The report is based on studies on 2018-2021 and provides forecast from 2022 till 2031 with 2021 as the base year. (Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.) In-depth qualitative analyses include identification and investigation of the following aspects: • Market Structure • Growth Drivers • Restraints and Challenges • Emerging Product Trends & Market Opportunities • Porter’s Fiver Forces The trend and outlook of North America market is forecast in optimistic, balanced, and conservative view by taking into account of COVID-19 and Russia-Ukraine conflict. The balanced (most likely) projection is used to quantify North America nutrigenomics market in every aspect of the classification from perspectives of Offering, Test Technology, Test Sample, Application, End User, and Country.

Based on Offering, the North America market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section. • Products o Probiotics o Prebiotics o Vitamins & Supplements • Testing Services o Nutrigenomics Clinical Testing o Nutrigenomics Research Testing Based on Test Technology, the North America market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section. • Next-generation Sequencing • Real-time PCR • DNA Microarray • Sanger Sequencing By Test Sample, the North America market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section. • Buccal Swab Sample • Saliva Sample • Blood Sample • Other Samples

Make this report your own

Have queries/questions regarding a report?

Take advantage of intelligence tailored to your business objective

Ask an Expert

Manmayi Raval

Research Consultant

By Application, the North America market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section. • Women’s Health • Metabolic Disorders • Immune Health • Cancer Research • Cardiovascular Diseases • Diabetes • Other Applications By End User, the North America market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section. • Hospitals • Nutrition Clinics • Diagnostics Laboratories • Other End Users Geographically, the following national/local markets are fully investigated: • U.S. • Canada • Mexico For each key country, detailed analysis and data for annual revenue ($ mn) are available for 2021-2031. The breakdown of national markets by Offering?Application and End User over the forecast years are also included.

Don’t pay for what you don’t need. Save 30%

Customise your report by selecting specific countries or regions

Specify Scope Now

The report also covers current competitive scenario and the predicted trend; and profiles key vendors including market leaders and important emerging players. Selected Key Players: BASF SE BioGaia Cell Logic Cura Integrative Medicine DNAfit DuPont de Nemours, Inc. Garden of Life, LLC GeneOmbio Genova Diagnostics, Inc. GX Sciences, Inc. Ingredion Incorporated Jarrow Formulas Inc. Koninklijke DSM N.V. MedGenome Metagenics, Inc. Nutrigenomix Inc. Unilever Group XCODE Life Yakult Honsha Co., Ltd. (Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)